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Alkali burn injury is a true ocular emergency of the conjunctiva and cornea that requires
immediate precision. Lack of an immediate therapy can lead to a substantial damage
in the ocular surface and anterior segment further causing visual impairment and
disfigurement. We explored the regenerative capability of dominant negative survivin
protein (SurR9-C84A) and histone deacetylase inhibitor trichostatin-A (TSA) in vivo, in
a rat alkali burn model. A topical insult in rat eyes with NaOH led to degradation of
the conjunctival and corneal epithelium. The integrity of the conjunctival and corneal
tissue was increased by TSA and SurR9-C84A by improving the clathrin and claudin
expressions. Wound healing was initiated by an increase in TGF-beta-1 and, increased
endogenous survivin which inhibited apoptosis post-TSA and SurR9-C84A treatments.
Protein expressions of fibronectin and alpha-integrin 5 were found to increase promoting
corneal integrity. The cytokine analysis confirmed increased expressions of IL-1beta,
IL-6, IL-12, IL-13, IFN-gamma, TNF-alpha, GMCSF, Rantes, and MMP-2 in injured
cornea, which were found to be significantly downregulated by the combined treatment
of SurR9-C84A and TSA. The ocular and systemic pharmacokinetic (PK) parameters
were measured post-topical ocular administration of TSA and SurR9-C84A. The SurR9-
C84A and TSA sustained relatively longer in the cornea, conjunctiva, and aqueous
humor than in the tear fluid and plasma. Our results confirmed that a combination of
TSA with SurR9-C8A worked in synergy and showed a promising healing and anti-
inflammatory effect in a very short time against alkali burn. Therefore, a combination of
TSA and SurR9-C84A can fulfill the need for an immediate response to wound healing
in alkali burnt cornea. We also synthesized ultra-small chitosan nanoparticles (USC-
NPs) targeted with alpha-SMA antibodies that can be used for delivery of TSA and
SurR9-C84A specifically to the ocular burn site.
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INTRODUCTION
Alkali burns of eye account for 11.5–22.1% of all ocular
traumas (Clare et al., 2012). Nearly two-thirds of such injuries
occur in young men. Alkali burns are reported to occur more
frequently than acid injuries (Wagoner, 1997). An alkali burn
of the cornea often leads to an extensive damage resulting in
a permanent visual impairment. The graveness of any ocular
injury generally depends on factors such as toxicity of the
chemical, exposure to chemicals, depth of penetration and the
area of injury. As alkaline agents are generally lipophilic in
nature, therefore, they can penetrate the tissues more rapidly
than acids. Roper Hall and Dua classification system is the
most widely accepted grading used to determine the level
of degree of corneal, conjunctival and limbal acute ocular
burns (Gupta et al., 2011). Alkali’s have the ability to saponify
the fatty acids of cell, cell membranes in order to penetrate
the corneal stroma, and destroy proteoglycans and collagen
content of the cell. The damaged tissues further secretes
proteolytic enzymes and inflammatory cytokines that lead to
enhanced damage of the eye (Fish and Davidson, 2010).
The current focus of medical strategies is to enhance the
recovery of corneal epithelium, supplement collagen synthesis,
minimizing collagen breakdown and controlling inflammation
simultaneously (Asbell and Khatib, 2011). Many therapeutics
have been used to prevent the cytokines and agents that
jeopardize the integrity of the eye post a chemical injury.
These therapeutics include corticosteroids, heparin, collagenase
inhibitors, contact lenses, fibronectin, conjunctival flaps and
corneal transplantation (Wagoner, 1997). However, due to the
lack of a patient-friendly treatment with an immediate effect
in preventing damage induced by alkali burns, treatment of
the alkali-burned eye continues to be a major challenge to the
ophthalmologist (Singh et al., 2013).
It has been reported that a 2-min topical treatment of histone
deacetylase (HDAC) inhibitor trichostatin A (TSA) on rabbit
corneas subjected to−9 D PRK substantially reduced the corneal
haze (Sharma et al., 2009). Systemic administration of TSA in
the ocular surface post-alkali-burn in a mouse model was found
to reduce the inflammatory and fibrotic responses mainly, by
inhibition of Smad signal in mesenchymal cells. The mitigation
of inflammatory responses was also induced by a failure in
activation and recruitment of macrophages (Kitano et al., 2010).
However, a higher dosage of TSA (100–300 ng) can affect the
chromatin structure and cause alterations in the DNA replication
patterns (Kemp et al., 2005). We synthesized a dominant
negative protein (SurR9-C84A) which replaced the depleted
endogenous survivin protein in normal brain cells, protected
them from T cell neurotoxicity, oxidative stress, and helped in
their proliferation (Baratchi et al., 2010, 2011a,b). Previously, we
analyzed the non-toxic nature of both these compounds and their
combination in a bovine corneal opacity alkali burn model where
we standardized the induction of alkali burn with NaOH. Our
findings uncovered that SurR9-C84A and TSA led to a substantial
improvement in the transmittance of light, improved the trans-
epithelial electrical resistance (TEER) and reduced the ocular
inflammation. Therefore, indicating the wound healing potential
of this formulation for topical applications in cases of alkali burn
(Bhasker et al., 2015; Lin et al., 2016).
Recently, we used these formulations in an alkaline burn rabbit
models (Roy et al., 2016). Further to extend the published study
we validated this work in another “rat model of alkali burn and
haze/scarring.” In the present study, we want to use the rat model
of scarring/haze to study, a number of biomarker reagents for rats
are readily available than rabbits (pathologic markers, cytokine
and apoptotic microarrays, primary and secondary antibodies)
to study the complete mechanism which confirms/validate the
pathways/molecules involved in humans. Therefore, in the
present study, we have made an attempt to evaluate the anti-
inflammatory and protective effects of SurR9-C84A, TSA and
their combination in altering the alkali burn adverse events in
a rat model. We also synthesized and characterized targeted
nanoparticle system for targeted delivery of TSA and SurR9-
C84A.
MATERIALS AND METHODS
Reverse Transcription-Polymerase Chain
Reaction to Evaluate the Effective Dose
Range of Therapeutics
This procedure was carried out using a previously published
protocol (Lin et al., 2016). Rat eyes were harvested from
humanely killed rats and washed with HBSS. Rat eyes were
further incubated with 1 M NaOH for 1 min and then treated
with TSA (0.002, 0.02, and 0.1 g/kg), SurR9-C84A (0.5, 1.2,
and 2.5 mg/kg), pSur/As-Sur (200, 200, and 800 µg/kg) and
empty plasmid (200, 400, and 800 µg/kg) for 40 min. Untreated
eyes were maintained as controls. After treatment period, eyes
were washed with PBS and total RNA was extracted using
the TRIzol R© reagent (cat# 15596-026, Thermo Fisher Scientific,
Waltham, MA, USA), and complementary DNA (cDNA) was
synthesized from RNA using the RevertAid H Minus First Strand
cDNA Synthesis Kit (cat# K1631, Thermo Fisher Scientific).
Expression of survivin, TGF-beta-1, alpha-SMA and collagen IV
was determined by polymerase chain reaction (PCR).
Rat Alkali Burn Model
This study was specifically approved by Deakin University
Animal Ethics Committee, Geelong under the ethics application
G12-2014. Seventy Wistar rats aged 10–12 weeks, were used for
this study as this model is well established in the literature for
corneal studies. The animals were housed and maintained in the
upper animal house Facility at the Deakin University, Waurn
Ponds campus, Geelong, VIC, Australia. Before starting the
treatments and disease induction, all the animals were thoroughly
examined for any signs of corneal abnormality. Before inducing
the general anesthesia, the rats were placed in a cage with oxygen
and pre-oxygenated.
Rat anesthesia was induced using a combination of propofol
(100 mg/kg), medetomidine (0.1 mg/kg), and fentanyl
(0.1 mg/kg) injected intraperitoneally. Once anesthesia was
induced the Isoflurane was administered at 1.5–2%. A 2.5 mm
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diameter filter paper, soaked in 1 M NaOH solution (pH 13.6),
and was placed over the central cornea in the right eye of
each animal. The excess/surplus fluid was discarded by a brief
contact with a clean absorbent filter paper. The cornea was
exposed for 1 min, the filter paper was discarded, and following
which the ocular surface was rinsed with the isotonic Hanks
balanced salt solution (HBSS). Cornea was then subjected to the
topical application of TSA (0.02 g/kg-dissolved in PBS), SurR9-
C84A (1.2 mg/kg-dissolved in PBS) and their combination
(TSA+SurR9-C84A) for 40 min. This dosage was determined
using a dose ranging study performed with rat eyes (Figure 1A).
In all groups, only the right eye of each animal was treated. The
left eye served as control and was treated with salt solution. Two
milliliters blood was collected from the jugular venous catheter at
(2, 10, and 30 min). Aqueous humor was collected post-humane
killing of the animals. 100–150 µL sample of aqueous humor was
withdrawn through a 27-gauge needle attached to a 1 ml syringe
by puncture of the eyeball. All experiments were performed
following the ethics approval G25-2014 and the guidelines from
AECG.
Histology Analysis
After the completion of the study, all tissues that required
to be examined (eyes, brain, kidneys, liver, spleen, heart and
lungs) were isolated. The cornea was carefully separated from
the eye without damaging it and washed using phosphate buffer
saline (PBS). Tissues were fixed using 4% paraformaldehyde (PF)
overnight at 4◦C and then washed in PBS. The tissue segments
were dehydrated in graded ethanol, embedded in paraffin and
5–7 µm thick sections were cut using a microtome. Sections were
collected on poly-lysine coated slides using the Leica cryostat and
were fixed immediately in ice-cold acetone. All the sections were
stained for haematoxylin–eosin (H&E) for critical analysis.
Immunofluorescence Studies in Cells
and Tissue Samples
Tissue slides were rehydrated by immersing in xylene (2 times
for 10 min), 100, 95, and 70% ethanol for 5 min each, deionized
water for 5 min. The antigen retrieval buffer (100 mM Tris,
5% w/v urea, pH 9.5) was pre-heated to 92–95◦C. Slides were
immersed in the pre-heated solution for 5–10 min. The tissues
were encircled with a hydrophobic barrier using a barrier pen.
Tissues were further blocked with 3% bovine serum albumin
(BSA) for 1 h. The slides were washed and incubated with
primary antibodies: mouse monoclonal anti-clathrin antibody
(BD biosciences, 1:100 dilution), rabbit anti-claudin antibody
(1:100 dilution, Santa Cruz, Australia), mouse monoclonal alpha-
SMA antibody (Santa Cruz: 1:100 dilution), mouse monoclonal
collagen type IV antibody (Santa Cruz: 1:100 dilution), D8-mouse
monoclonal anti-survivin, (Santa Cruz: 1:100 dilution) for 1 h at
37◦C. Post-washing thrice with PBS, the slides were incubated
with fluorescein isothiocyanate (FITC) (anti-mouse, anti-rabbit
FITC, Sigma–Aldrich) conjugated secondary antibody (1:100) for
1 h in dark. The slides were washed and mounting media with
DAPI was added to the slides. The slides were viewed using Leica
TCS SP5 laser scanning confocal microscope.
Analysis of Pro and Anti-inflammatory
Cytokines
The cytokine profiling was performed using the Rat
Inflammatory Cytokines & Chemokines Multi-Analyte
ELISArray Kit (QIAGEN, USA). Briefly, serial dilutions of
the Antigen Standard and the experimental samples were
prepared. 50 µL of Assay Buffer was added to each well of
the 8-well ELISA strips. Fifty microliters samples and/or
standards were added to the appropriate wells of the ELISA
strips and incubated for 2 h at room temperature. The ELISA
strips were further washed using 350 µL 1 × Washing Buffer
thrice. Hundred microliters of Detection Antibody solution
was added to the ELISA strips and incubated for 1 h at room
temperature. ELISA wells were washed as mentioned above.
Hundred microliters of the Avidin–HRP solution was added to
all wells and incubated for 30 min at room temperature. ELISA
wells were washed as mentioned above. Hundred microliters of
Development Solution was added to each well and incubated for
15 min at room temperature in the dark. Hundred microliters of
Stop Solution was added to each well. The color changed from
blue to yellow. The absorbance at 450 nm was measured within
30 min of stopping the reaction. The estimation of pg/mL of
cytokines was performed using the values obtained from antigen
standards and a graph was plotted for the cytokine expression
with the effect of treatments.
Gene Expression Analysis
In order to detect the fold change in gene expressions quantitative
real-time polymerase chain reaction (qRT-PCR, iQ-5, Bio-Rad,
Australia) was used. RNA was isolated from the tissues using
TRizol (Invitrogen, Australia) and isolated RNA had been
immediately subjected to cDNA synthesis. The cDNA thus
synthesized was stored at −80◦C and was further used for a
qRT-PCR chain reaction.
Western Blotting
The tissues were homogenized and lysates were obtained
by incubating homogenized tissue in radioimmunoassay
precipitation (RIPA) buffer for 20 min at 4◦C, followed by
centrifugation at 14,000 rpm for 15 min at 4◦C. The Bio-Rad
Bradford assay (Bio-Rad Laboratories, Inc., Berkeley, CA,
USA) was used to determine the protein concentration of the
cellular extracts. Thirty milligrams of protein extracts were
electrophoresed on 4–12% Bio-Rad gel. Transfer of proteins
from the SDS–polyacrylamide gel onto the polyvinylidene
difluoride (PVDF) membrane was carried out using Bio-Rad
(Australia) trans-blot turbo transfer system. Following the
transfer, blocking of membrane with 2% skimmed milk was
performed for 1 h and the membrane was washed thrice
with tris–buffer saline with tween 20 (TBST) and thrice with
TBS. After the washing steps, the membrane was incubated
with primary antibodies-mouse monoclonal anti-clathrin
antibody (BD biosciences, 1:1000 dilution), rabbit anti-claudin
antibody (1:1000 dilution, Santa Cruz, Australia), D8-mouse
monoclonal anti-survivin, (Santa Cruz: 1:1000 dilution), mouse
monoclonal TGF-beta-1 antibody (Santa Cruz: 1:1000 dilution),
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FIGURE 1 | Change in corneal tissue integrity post-alkali burn: (A) Gene expression analysis to determine the effective dosage of TSA and SurR9-C84A using
ex vivo rat eyes. (B) Rat eyes were exposed to 1 M NaOH for 1 min and then treated with TSA or SurR9-C84A or a combination of both [TSA+SurR9-C84A(SR9)] for
40 min. The excised eyes were used to determine the opacity and inflammatory scores and H&E staining was performed to determine the effect of alkali burn and
treatments on corneal tissue integrity. (C) Immunofluorescence staining for expression of clathrin in conjunctival layer and claudin in corneal layer was performed to
determine the effect of alkali burn and treatments on corneal tissue integrity. (D) Western blotting analysis confirmed that both decrease in expressions of clathrin
and claudin in rat corneal tissue lysates. Each blot was repeated thrice and a representative blot has been presented. (E) Band density analysis of western blot was
performed using image J software. The experiments were conducted in five animals per treatment group. The H&E staining was performed on five slides obtained
from each animal and a representative image has been presented. Five images of each treatment were taken for immunofluorescence studies and a representative
image has been presented. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001.
mouse monoclonal alpha-SMA antibody (Santa Cruz: 1:1000
dilution), mouse monoclonal Fibronectin-1 antibody (Santa
Cruz: 1:1000 dilution), mouse monoclonal collagen type IV
antibody (Santa Cruz: 1:1000 dilution), rabbit anti-GAPDH
(Santa Cruz, 1:1000), overnight at 4◦C. The washing steps
were repeated and then incubated with the corresponding
horseradish peroxidase (HRP) conjugated secondary antibodies
(R&D biosciences rabbit anti-mouse HRP, goat anti-rabbit
HRP: 1:1000 dilution) for 1 h at 37◦C. The washing steps
were repeated again and the membrane was developed using
HRP substrates (GE healthcare, Australia). The membrane
was visualized using Bio-Rad-Australia, Chemi-doc with XRS
camera.
Mean Opacity Measurements and Mean
Permeability Measurements
The mean in vivo scores was determined using the mean
opacity measurements. The rat eyes were excised carefully
and carried to the laboratory in HBSS supplemented with
penicillin/streptomycin. The measurement of mean opacity
was carried out using an opacitometer which measures the
transmission of light through the center of each mounted
cornea. The mean permeability score was determined by
adding a fluorescent (rhodamine solution) on the anterior
side of the holder and the corneas were incubated in a
horizontal position for 90 min at 32◦C. The medium in
the posterior chamber was removed and added to 96 well
plates and the OD at 490 nm was read. The readings
obtained at OD490 were used to determine the permeability
of each treatment with respect to the change in the untreated
corneas.
Blood Analysis
The analysis of blood samples was performed directly using the
ABX Micros ES 60 (Horiba Medicals). The parameters analyzed
included the number of red blood cells (RBC’s), white blood cells
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(WBC’s), platelets and hemoglobin content. Briefly, 20 µL of the
blood sample was acquired in the instrument and the readings
were recorded.
Pharmacokinetics
Pharmacokinetic analysis was done using the HPLC System
for the levels of TSA in eye tissue and plasma samples was
measured using PK methods. PK estimated using standard
measurements for maximum concentration (Cmax), time to
reach Cmax (Tmax), area under the concentration–time curve
(AUC), elimination rate constant (K), elimination half-life (t1/2),
apparent clearance (CL/F), apparent volume of distribution
(Vd/F).
Synthesis and Characterization of
Alpha-SMA Targeted Ultra-small
Chitosan Nanoparticles (USC NPs)
The synthesis of USC NPs was carried out using a previously
published protocol (Sunkireddy et al., 2016). Briefly, 5.0 mL of
aqueous STPP (2.0 mg/mL) was added drop-wise in 10.0 mL
of low molecular weight chitosan (0.225% w/v in 1% v/v acetic
acid) kept in a 25.0 mL beaker at room temperature while
stirring at 600 rpm. The reactants were allowed to react under
similar stirring conditions for 1 h after addition of STPP. To
synthesize protein encapsulated ultra-small CS NPs, 5.0 mL of
aqueous STPP (2.0 mg/mL) containing SurR9-C84A (4 mg/mL)
was added drop-wise in 10.0 mL of chitosan kept on 25.0 mL
beaker at room temperature. The components were stirred
for 1 h after dropping STPP and SurR9-C84A to achieve the
successful encapsulation of SurR9-C84A. These nanoparticles
are not separable by centrifuging hence, in order to remove
the unreacted STPP and unencapsulated proteins they were
dialyzed using a 100 kDa dialysis tubing. The suspension
was then added to 30 mg of EDC and 15 mg of NHS and
stirred for 30 min (Roy et al., 2016). The alpha-SMA antibody
suspension (100 µg/mL in 3 mL of PBS) was added dropwise
at room temperature (25 ± 5◦C) under sustained magnetic
stirring for 12 h. The solution was dialyzed using a 100 kDa
dialysis tubing to remove unreacted antibody and EDC or
NHS.
Scanning electron microscopy (SEM, Supra 55vp Zeiss) was
used to observe the surface morphology, size, and shape of the
nanoparticles. To measure the thermal stability and water holding
capacity of the nanoparticles differential scanning colorimeter
(DSC, TA-Q series) was used. Fourier transform infra-red
spectroscopy (FTIR) was used to study the chemical nature and
complex structure of both void and alpha-SMA targeted USC
NPs.
In Vitro and Ex Vivo Internalization of
Targeted USC NPs
The time-dependent in vitro NP internalization of the ultra-small
CS NPs in MIOM1 (Müller glial cells) was determined using
confocal microscopy. Cells were grown in FalconTM six-well
culture slides (BD Biosciences, San Jose, CA, USA) at a density of
2 × 104 cells/well and incubated with rhodamine-labeled ultra-
small CS NPs at time points of 30 min. After the treatment, the
media were discarded and cells were washed using PBS in order
to remove the unbound NPs. The cells were fixed using 4% PF for
20 min. DAPI (4′,6-diamidino-2-phenylindole) was added to the
cells and a cover slip was placed on the slide. The slide was viewed
using the confocal microscope (Leica TCS SP5).
Eyes excised from humanly euthanized rats were transported
to the laboratory in HBSS. Sterile PBS was used to wash the
eyes and then eyes were incubated with 5 mg/ml of cyanine 5.5
labeled ultra-small CS NPs for 30 min. Following the treatment,
eyes were carefully washed using PBS and imaged using Caliper
Life Sciences in vivo imaging system using the Living Image 4.3.1
software (Sunkireddy et al., 2016).
Statistical Analysis
Statistical analysis was performed by unpaired Student’s t-test
using online Graphpad software on the triplicate data generated
from individual or triplicate experiments. (∗) P < 0.05, (∗∗)
P < 0.01 and (∗∗∗) P < 0.001.
RESULTS
Regenerative and Protective Effects of
TSA and SurR9-C84A
Ex vivo analysis was performed to determine the effective dosage
of TSA and SurR9-C84A required to inhibit the expression
of survivin, TGF-beta-1, alpha-SMA and collagen IV in alkali
bunt cornea. It was observed that 0.02 mg/kg of TSA and
1.2 mg/kg of SurR9-C84A were most effective in inhibiting
expression of survivin, alpha-SMA, TGF-beta-1 and collagen
IV (Figure 1A). The rat alkali burn induced by NaOH led to
extensive damage to the ocular surface and the anterior segment
which induced ocular disfigurement and could also have caused
a visual impairment (Figure 1B). The rat eyes were excised and
examined for the pathological symptoms and according to the
severity of damage a grading was performed (Table 1). The mean
opacity, permeability, and irritation were measured in the rat eyes
and the scores revealed that induction of alkali burn using NaOH
led to a moderate irritation in rat eye whereas use of TSA and
SurR9-C84A effectively led to a decrease in opacity, permeability
and in vitro scores.
The H&E sections (Figure 1B) obtained from the corneal
segments clearly revealed that the NaOH insult led to damage
of the conjunctival layer and the corneal matrix creating large
vacuoles. Treatments with TSA and SurR9-C84A led to the
recovery of the conjunctival layer, however, the corneal matrix
was unable to heal completely. However, the combination
of TSA and SurR9-C84A led to a substantial recovery as
both the conjunctival layer as well as the corneal matrix
showed improved physiology. Further analysis was carried out
using immunofluorescence where the conjunctival integrity and
corneal integrity was found to be severely damaged as the
clathrin and claudin expressions (Figure 1C) respectively, were
substantially lowered post-NaOH insult. SurR9-C84A was found
to be more effective than TSA alone in reviving both the clathrin
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TABLE 1 | Measure of opacity, permeability, and irritation.
Treatment Mean opacity measurement Mean permeability measurement Mean in vitro score Predicted irritation potential
Control eye 0.0 0.0 0.0 No irritation
Alkali burn (NaOH) 2.5 ± 0.5∗∗ 0.80 ± 0.5∗∗ 10.2 ± 0.5∗∗∗ Moderate irritation
NaOH–TSA 0.5 ± 0.2 ∗ 0.15 ± 0.5∗ 0.20 ± 0.5∗ No irritation
NaOH–SuR9-C84A 0.0∗ 0.0∗ 0.0∗ No irritation
NaOH–SuR9-C84A+TSA 0.0∗ 0.0∗ 0.0∗ No irritation
Total number of animal (n) = 4. ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗p < 0.001.
and claudin expressions in the conjunctival and corneal layer
but the combination of both TSA and SurR9-C84A was found
to most effective as the expressions of both these proteins were
nearly same as that of control cornea. In order to confirm
these findings western blotting was performed using the rat
corneal lysates (Figure 1D). The results revealed that there was
a substantial increase (1.947-fold) in clathrin expression in rat
eyes treated with TSA+SurR9-C84A post-NaOH insult when
compared to the alkali burnt eye. A similar trend was observed
in the claudin expression where alkali insult led to a decrease
in the claudin expression and there was a substantial increase
(1.33-fold) in claudin expression in rat eyes treated with
TSA+SurR9-C84A post-NaOH insult when compared to the
alkali burnt eye (Figure 1E).
Gene Expression Analysis of Key Wound
Healing Proteins and Inflammatory
Cytokines
Gene expression analysis was carried out to determine the
expressions of key regulators of cell survival, morphology wound
healing, and inflammation. The qRT-PCR analysis revealed that
survivin expression was significantly increased (p < 0.001) in
rat eyes treated with SurR9-C84A and TSA+SurR9-C84A post-
alkali burn. TGF-beta-1 expression was found to increase post-
NaOH insult and was found to further increase with TSA
(P < 0.001) and SurR9-C84A treatments (p < 0.01). The alpha-
integrin 5 expression was lowered post-NaOH insult whereas,
treatments with TSA led to a significant increase (p < 0.001) in
both alpha-integrin 5 and alpha-SMA (p < 0.001) expressions.
SurR9-C84A and TSA+SurR9C84A, on the other hand, led to
a significant decrease (p < 0.001) in alpha-SMA expression.
Fibronectin-1 expression was also found to be significantly
enhanced by TSA (p < 0.001), SurR9-C84A (p < 0.001)
and TSA+SurR9-C84A (p < 0.001). Insult with NaOH led
to an increase in Collagen type IV expression which was
found to be efficiently downregulated by TSA (p < 0.001),
SurR9-C84A (p < 0.001) and TSA+SurR9-C84A (p < 0.001)
(Figure 2A).
IL-1 beta expression was found to be decreased with NaOH
insult and both TSA (p < 0.001) and SurR9-C84A (p < 0.001)
led to an increase in its expression. However, TSA+SurR9-C84A
did not lead to any increase in IL-1 beta. IL-6 and TNF-alpha
expressions were found to be increased post-insult with NaOH
and were found to be significantly lowered with TSA (p < 0.001)
alone followed by TSA+SurR9-C84A treatments (p < 0.001).
MMP-2 expression was also found to increase with NaOH and
treatments and TSA+SurR9-C84A was the most effective in
downregulating (p < 0.001) MMP-2 followed by SurR9-C84A
and TSA. MMP-9 expression was lowered post-NaOH treatments
whereas, treatments with TSA+SurR9-C84A led to a significant
increase (p< 0.001) in MMP-9 expression (Figure 2B).
Ocular and Systemic Pharmacokinetics
of TSA
Trichostatin-A concentration was determined after topical
application of TSA and TSA-SurR9-C84A in rat eyes and plasma
(Tables 2, 3). The maximum concentration (Cmax) of TSA in
different ocular tissue and plasma were measured. It was also
found that the elimination half-life of TSA in cornea, conjunctiva,
and aqueous humor was relatively longer than that in tear fluid
and plasma.
Effect of Combination of TSA and
SurR9-C84A on Corneal Membrane
Integrity Post-alkali Burn
Confocal microscopy was carried out in order to determine the
protein expressions of key proteins regulating cell morphology
(Figure 3A). Survivin expression was found to be slightly
increased post-NaOH insult and treatments with SurR9-C84A
and TSA+SurR9-C84A led to an increase in survivin expression.
It was observed that alpha-SMA expression was substantially
enhanced post-NaOH insult and TSA treatments failed to
downregulate it effectively. SurR9-C84A and TSA+SurR9-C84A
led to substantial decrease in alpha-SMA expression. The
expression of collagen type IV was found to be downregulated
by NaOH whereas treatments with TSA were found to be the
most effective in increasing the collagen type IV expression
followed by TSA and TSA+SurR9-C84A. In order to confirm
these findings western blotting was performed to determine the
expression of key proteins (Figure 3B). The results revealed
that survivin expression was substantially increased post-
SurR9-C84A (7.7-fold) and TSA+SurR9-C84A (13.1-fold)
treatments. TGF-beta-1 expression was found to be substantially
increased post-TSA+SurR9-C84A (threefold) followed by
SurR9-C84A (2.4-fold) and TSA (1.45-fold) treatments. Alpha-
SMA expression was found to be substantially increased
post-NaOH insult (2.7-fold). Treatments with SurR9-C84A
(6.75-fold) and TSA+SurR9-C84A (15-fold) led to an effective
downregulation of alpha-SMA. Fibronectin-1 expression was
found to be significantly enhanced by TSA (1.97-fold), SurR9-
C84A (1.97-fold) followed by TSA+SurR9-C84A treatments
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FIGURE 2 | Quantitative real-time PCR for expression of wound healing, tissue integrity and inflammatory markers: (A,B) The qRT-PCR analysis was
carried out to determine the gene expressions of wound healing markers survivin, TGF-beta-1, tissue integrity markers alpha integrin 5, Fibronectin-1, alpha-SMA,
collagen type IV and inflammatory markers IL-1 beta, IL-6, MMP-2, MMP-9 and TNF-alpha. (SR9=SurR9-C84A). The experiments were conducted in triplicates.
∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001.
TABLE 2 | Concentration of TSA in tissues and plasma after topical application in eye.
Time (min) Plasma
(ng/mL, mean ± SD)
Aqueous humor
(ng/mL, mean ± SD)
Cornea
(µg/g, mean ± SD)
Conjunctiva
(µg/g, mean ± SD)
Tear fluid
(µg/g, mean ± SD)
0 0 0 0 0 0
2 70.50 ± 5.5 52,400 ± 500 20.50 ± 15.5 20.20 ± 5.5 2,250 ± 550
10 140.50 ± 50.0 5,200 ± 350 45.00 ± 10.5 20.05 ± 5.5 1,250 ± 55
30 50.50 ± 10.0 4,200 ± 450 15.05 ± 5.5 10.50 ± 4.5 500 ± 55.5
Frontiers in Pharmacology | www.frontiersin.org 7 May 2017 | Volume 8 | Article 223
fphar-08-00223 May 3, 2017 Time: 15:31 # 8
Roy et al. Topical Ophthalmic Formulation for Alkali Burn
TABLE 3 | Pharmacokinetics of TSA in rat eye tissues and plasma after topical application.
Pharmacokinetic parameters Plasmaa Aqueous humorb Cornea Conjunctiva Tear fluid
Cmax (µg/g) 160.3 ± 61.0 11,046 ± 2734 44.67 ± 12.91 26.26 ± 7.19 2,987 ± 1814
Tmax (h) 0.167 0.333 0.0833 0.0833 0.0833
t1/2 (h) 1.5 1.5 3.5 4.2 2.3
CL/F (µg/h) 12.6 0.5 7.5 11.5 1.0
Vd/F (µg) 34.5 0.6 35.5 45.5 2.0
AUC0−8 (µg h/g) 65.5 7568 45.5 53.4 678.5
AUC0−∞ (µg h/g) 68.4 7689 55.5 51.70 768.5
Apparent clearance = CL/F and apparent volume of distribution = Vd/F. a,bUnit for plasma/aqueous humor = ng/mL, Cmax = L/h, L/ng h/mL and AUC = CL/F, Vd/F.
FIGURE 3 | Analysis of protein expression for key tissue integrity markers: (A) Immunofluorescence staining was performed for expression of alpha-SMA,
collagen type IV and survivin in rat corneal tissues. (B) Western blotting analysis was performed to confirm the protein expressions of survivin, TGF-beta-1,
alpha-SMA, Fibronectin-1 and collagen type IV in rat corneal lysates. Each blot was repeated thrice and a representative blot has been presented. (C) Band density
analysis was carried out for the western blots using the image J software. (SR9=SurR9-C84A). Five images of each treatment were taken for immunofluorescence
studies and a representative image has been presented. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001.
(1.71-fold). In the case of collagen type IV, a slight decrease was
observed with NaOH insult (1.1-fold) and treatments with TSA
(2.8-fold) and TSA+SurR9-C84A (2.42-fold) led to an effective
downregulation of collagen type IV (Figure 3C).
Analysis of Key Inflammatory and
Anti-inflammatory Cytokines in Alkali
Burn
Multianalyte ELISA test was conducted to determine the
expression of inflammatory cytokines in the corneal lysate. The
results revealed that IL-2 expression was significantly increased
(p < 0.01) with treatments of TSA and SurR9-C84A. In the case
of IL-4 NaOH treatments led to a decrease in expression. The
expression of IL-4 was found to increase with treatments of TSA
(p< 0.01) and SurR9-C84A (p< 0.01). The IL-1 alpha expression
was found to significantly increase with SurR9-C84A (p < 0.05)
treatments and was significantly reduced by TSA+SurR9-C84A
(p < 0.05) treatments. The IL-1 beta expression was also found
to increase post-NaOH insult. Treatments with SurR9-C84A led
to a further increase (p < 0.05) in IL-1 beta whereas, treatments
with TSA and TSA+SurR9-C84A led to a significant (p < 0.05)
downregulation. A similar pattern in expressions of IL-6, IL-13,
TNF-alpha and GMCSF was observed. Their expression was
enhanced with NaOH insult and downregulated effectively by
both TSA and TSA+SurR9-C84A (p < 0.05) treatments. In the
case of IL-10, NaOH led to a significant increase (p < 0.01)
and treatments of TSA+SurR9C84A led to an effective decrease
(p < 0.05) in its expression (Figure 4A). The IL-12 expression
was decreased by NaOH insult and treatments with TSA and
TSA+SurR9-C84A led to a further downregulation (p < 0.05) in
the expression of IL12. IFN-gamma was found to be upregulated
with NaOH insult and treatments with TSA and TSA+SurR9-
C84A led to a significant downregulation (p < 0.05) in the
expression of IFN-gamma. It was also observed that Rantes was
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FIGURE 4 | ELISA for expression of pro-inflammatory and anti-inflammatory cytokines: (A,B) The ELISA array was performed to determine the expression
of pro-inflammatory cytokines IL-1 alpha, IL-1 beta, IL-2, IL4, IL-6, IL-12, IFN-gamma, TNF-alpha and Rantes and anti-inflammatory cytokines such as IL-10, IL-13,
GMCSF. (SR9=SurR9-C84A). The experiments were conducted in triplicates. ∗p < 0.05 and ∗∗p < 0.01.
upregulated by NaOH insult and significantly downregulated by
TSA (p< 0.05) treatments (Figure 4B).
Histopathology and Blood Analysis for
Signs of Toxicity
The histopathology of key organs such as brain, spleen, liver,
kidney, and heart was conducted in order to observe any
signs of cytotoxicity or adversity due to any of the treatments
(Figure 5). No substantial change was observed in the tissue
sections from all organs of the treated rats. The blood analysis
was carried out to determine the effect of alkali burn and the
treatments on various parameters of blood (Table 4). It was
observed that in the untreated rats the hemoglobin (HGB)
count was higher than normal, this count was decreased by
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FIGURE 5 | Histology analysis for signs of toxicity: The vital organs from treated and control rats such as brain, spleen, liver, kidney and heart were
analyzed using H&E staining for signs of toxicity post-insult with NaOH and treatments with TSA, SurR9-C84A and TSA+SurR9-C84A (SR9). The H&E
staining was performed on five slides obtained from each animal and a representative image has been presented.
TABLE 4 | Blood analysis.
Parameters Untreated NaOH NaOH–TSA NaOH–SurR9-C84A NaOH–TSA–SurR9-C84A
WBC 8.15 ± 2.02 3.4 ± 1.19 5.48 ± 2.06 1.3 ± 3.18 8.8 ± 2.43
RBC 9.10 ± 0.41 6.53 ± 2.89 8.15 ± 0.61 8.35 ± 0.99 9.51 ± 0.82
HGB 18.66 ± 1.01 14.61 ± 5.35 17.61 ± 1.41 17.1 ± 1.11 18.75 ± 1.69
HCT 50.71 ± 2.36 40.71 ± 1.76 46.2 ± 4.14 46.85 ± 4.14 52.98 ± 4.07
MCV 55.66 ± 0.51 62.5 ± 8.01 56.66 ± 1.86 55.66 ± 1.86 47.5 ± 2.08
MCH 20.5 ± 0.55 23.45 ± 4.36 21.63 ± 1.01 20.36 ± 1.42 19.73 ± 0.70
MCHC 36.81 ± 1.39 37.51 ± 4.79 38.15 ± 1.63 36.61 ± 1.57 35.58 ± 1.04
PLT 334.16 ± 116 487 ± 166 256.33 ± 117 547.16 ± 130 409.66 ± 135
WBC, white blood cells; RBC, red blood cells; HGB, hemoglobin; HCT, haematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean
corpuscular hemoglobin concentration; PLT, platelets.
NaOH insult whereas treatments with TSA+SurR9-C84A led to
an increase in HGB. The hematocrit (HCT) count was found
to be lower than normal range in the case of NaOH treated
rats. Treatments with TSA, SurR9-C84A, and TSA+SurR9-
C84A effectively increased the HCT count to normal range.
The mean corpuscular HGB count was found to be higher
than normal in NaOH treated rats which were effectively
reduced to normal range upon treatments with TSA, SurR9-
C84A, and TSA+SurR9-C84A. The platelet count in untreated
rats was found to be low in untreated rats and was increased
by treatments with NaOH, SurR9-C84A, and TSA+SurR9-
C84A.
Characterization of Alpha-SMA Targeted
Ultra-Small Chitosan Nanoparticles
(USC NPs)
The USC NPs were synthesized and characterized using SEM
(Figure 6A) and FTIR. The infra-red spectrum of void USC NP
was compared to that of alpha-SMA targeted USC NPs using
FTIR. For void USC NPs, the characteristic NH2 and OH group
stretching peak was observed at 3425 cm−1. The peaks were
wider in the case of alpha-SMA targeted USC NPs (3432 cm−1)
suggesting an increase in the number of OH bonds. The NH2
stretching peak for void USC NPs was observed at 1640 and
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FIGURE 6 | In vitro and ex vivo internalization efficacy of alpha-SMA targeted USC NPs: (A) SEM images confirmed uniform shape and size (50–60 nm) of
both void and alpha-SMA targeted USC NPs. (B) FTIR analysis confirmed successful conjugation of anti-body represented by the sharp primary amine peak at
1640 cm-1 in spectra of alpha-SMA targeted USC NPs. (C) Confocal microscopy revealed that alpha-SMA targeted USC NPs showed substantially higher
internalization in MIOM-1 cells when compared to void USC NPs. (D) Graphical representation of confocal images showing internalization efficacy of alpha-SMA
targeted USC NPs over void USC NPs. (E) Ex vivo internalization analysis also confirmed that alpha-SMA targeted USC NPs showed higher internalization efficacy
than void USC NPs. The experiments were conducted in triplicates. Five images of each treatment were taken for immunofluorescence studies and a representative
image has been presented. ∗∗∗p < 0.001.
1559 cm−1, and for alpha-SMA targeted USC NPsat 1403 cm−1,
the peaks for targeted USC NPs were again broad suggesting
an interaction between NH+3 of chitosan and STPP. The CH
deformation vibration peak for void USC NPs was at 1412 cm−1
whereas for targeted USC NPs nanoparticles were at 1421 cm−1
and shorter than that of void NPs. The P=O group peak was
observed at 1095 cm−1 for void NPs, and at 1098 cm−1 for
alpha-SMA targeted USC NPs (Figure 6B).
In Vitro and Ex Vivo Internalization
Efficacy of Alpha-SMA Targeted USC
NPs
Confocal microscopy was conducted in order to test the
internalization of Void USC NPs and alpha-SMA targeted
USC NPs in MIOM1 cells (Figure 6C). It was observed that
post 30 min of incubation the void NPs showed successful
uptake in MIOM1 cells, however, a higher and more efficient
internalization was observed in the case of alpha-SMA targeted
USC NPs (Figure 6D).
The internalization efficacy was also carried out in an ex vivo
rat eye model. The nanoparticles were incubated with whole rat
eyes for 30 min and post-washing, the eyes were examined using
IVIS. It was evident that the rat eyes treated with alpha-SMA
targeted USC NPs showed higher fluorescence intensity than
the void USC NPs. The eyes were then frozen overnight and
cross-sectionally segmented. The cross-sectional sections were
also examined using IVIS and it was found that a high intensity of
fluorescence intensity proportional to alpha-SMA targeted USC
NPs was observed (Figure 6E).
DISCUSSION
Several studies have focused on control and prevention of
alkali burn as it’s a very common and has severe effects
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(Pattamatta et al., 2013; Ambrosone et al., 2014; Okada et al.,
2014; Yang et al., 2015). Alkali burns can destroy not only
the corneal epithelium but also the corneal stroma, by creating
large vacuolated structures (Zhang et al., 2005). In the present
study, large vacuoles were found in the corneal stroma in
eyes post-NaOH insult. In our previous study, we found that
combination treatment of dominant negative survivin mutant
(SurR9-C84A) and histone deacetylase inhibitor trichostatin-A
(TSA) is effective for maintaining the corneal tissue’s integrity
in rabbit alkaline burn model (Roy et al., 2016). Moreover,
including additional biomarkers of the disease pathway in
the proposed rat model, will give a better understanding of
haze/scarring mechanisms and will provide more information
on the effectiveness of the treatment for future work in human
trials. Treatments with TSA, SurR9-C84A, and TSA+SurR9-
C84A led to healing of both corneal epithelium and corneal
stroma as seen by the images from the eye and the H&E
sections. It has been reported earlier that TSA led to the
recovery of rat corneal cells within a span of just 2 min of
topical administration after induction of alkali burn (Sharma
et al., 2009). Clathrin protein is generally found in epithelial
cells of conjunctiva and is responsible for regulation of
intracellular segregation and transportation of matter into the
eye (Qaddoumi et al., 2003). Thus, during ocular drug delivery
change in expression of conjunctival clathrin has been related to
conjunctival inflammation and damage (Gukasyan et al., 2008).
Claudin transmembrane protein that acts as a barrier molecule
by regulating the cell–cell interaction and tight junctions along
with tight junction protein ZO-1, to maintain the membrane
structure of corneal epithelial cells (Peltonen et al., 2007). Claudin
is responsible for sealing the adjacent cells and tightening of
the paracellular spaces to prevent the passage of the solutes
through the corneal membranes (Krause et al., 2008; Contreras-
Ruiz et al., 2012). Therefore, disruption of claudin is a sign
of corneal toxicity and damage. Both clathrin and claudin
expressions were found to be substantially lowered by NaOH
treatments, whereas further treatments with TSA+SurR9-C84A
(found to be the most effective) led to conjunctival and
corneal healing by reviving the expressions of both clathrin and
claudin.
Alkali burn has been reported to downregulate expressions
of alpha integrins, fibronectins, and alpha-SMA (Fish and
Davidson, 2010). Fibronectin has a favorable effect on
promoting epithelialization (Singh et al., 2013). Treatments
of TSA post-NaOH was found to be the most effective
in increasing fibronectin expression followed by SurR9-
C84A and TSA+SurR9-C84A. During wound healing, the
keratocytes that migrate to injured stroma transform into
myofibroblasts. These myofibroblasts express high levels
of alpha-SMA (Ishizaki et al., 1993). Although treatments
of TSA led to an increase in expressions of alpha-SMA,
treatments with SurR9-C84A and TSA+SurR9-C84A did
not increase the alpha-SMA levels to very high. Expression
of collagen type IV is generally determined to investigate
the changes in the corneal epithelial basement membrane
following an alkali burn (Saika et al., 1995). It was observed
that collagen type IV expression was significantly increased
post-NaOH insult but treatments with TSA and TSA+SurR9-
C84A lowered it effectively. Increased collagen type IV has
been often related with increased corneal haze (Kaji et al.,
2001).
Alkali burn is known to generate a severe inflammatory
response and attract the inflammatory cells toward the
site of injury (Kenyon, 1985). Continued infiltration of the
inflammatory cells can suspend the corneal re-epithelialization,
and lead to ulceration and permanent visual loss (Kenyon,
1979, 1982). The exact profile of the various cytokines and
their relative expressions during damage and repair processes
in the alkali-burned cornea is yet to be elucidated. Research
done over the past several years has made it clear that corneal
epithelial cells can express and produce IL-1beta (Wilson
et al., 1992); corneal epithelial, stromal and endothelial
cells can produce IL-6 (Sakamoto et al., 1991); and corneal
epithelial and stromal cells can express and produce IL-8
(Cubitt et al., 1993). The wound healing process, on the
other hand, is regulated by several signals initiated from these
cytokines.
IL-1beta, IL-6, and TNF-alpha are commonly known to
be expressed in alkali-burned corneas, and IL-6, in particular,
has been reported to be strongly induced soon after alkali
burn injury in mice (Sotozono et al., 1997). It has also
been reported that IL-1 alpha was predominantly present in
regenerated corneal epithelial cells, especially in basal cells
(Sotozono et al., 1997). Wilson et al. (1996) have suggested
that IL-1 alpha and IL-1beta are inflammatory modulators
released from the injured epithelium that serves as injury
transducers, leading to keratocyte apoptosis. Because IL-1alpha
and IL-1beta use the same receptors in a variety of cells, it is
assumed that they have similar biological activities (Dinarello,
1991).
IL-6 is generally not expressed in unburned corneal epithelium
(Sotozono et al., 1997). However, in alkali burnt corneas
increased expressions of IL-6 have been reported (Sotozono
et al., 1997). A dramatic increase in expressions of IL-1
alpha and IL-6 has been reported during the early stages of
alkali burn (Li et al., 2001). Inflammatory cytokines such as
IL-1, IL-6 and IL-8 lead to infiltration of polymorphonuclear
leukocytes (PMNs) that produce more inflammatory cytokines.
The PMNs also produce superoxide, prostaglandins and release
lysosomal enzymes. IL-1 has also been reported to induce the
expression of MMP family of enzymes in alkali burnt corneal
stromal cells (Li et al., 2001), that further leads to corneal
and stromal damage. Thus, it can be assumed that IL-1 is the
initiator of the inflammatory response or the trigger to the
cascade of pathways associated with corneal damage post-alkali
burn. MMPs such as MMP-2 and MMP-9 are zinc-dependent
extracellular endoproteinases that disrupt cell-to-cell and cell-to-
extracellular matrix connections and facilitate the migration of
endothelial cells to areas stimulated by VEGF, ultimately leading
to the formation of new vasculature and redness of the eye
(Kvanta et al., 2000).
Histone deacetylase inhibitors effect the cell death by
altering the acetylation of non-histone proteins therefore, it is
reported that they may be anti-inflammatory (Adcock, 2007).
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FIGURE 7 | Alpha-SMA targeted USC NPs for delivery of TSA and SurR9-C84A to the burn site and reverses corneal haze by inducing apoptosis in
TGF-beta-1 induced transformed myofibroblast cells: The alpha-SMA targeted USC NPs have the potential for specifically delivering majority of the
therapeutic to the burn site in a sustained release manner thus ensuring a longer activity period of the therapeutics. The combinatorial treatment of
SurR9-C84A and TSA can repair of the conjunctival and corneal integrity by reinstating expression of clathrin and claudin without inducing any non-specific
cytotoxicity. TSA and SurR9-C84A treatment increased expression of survivin: preventing apoptosis, TGF-beta-1: initiating wound healing, fibronectin, and alpha
integrin: reinstating the corneal integrity. Key markers of corneal haze progression (alpha-SMA and collagen type IV) were effectively downregulated therefore
reducing the risk of myofibroblast formation.
A study has shown that TSA substantially downregulated both
the mRNA and protein expressions of the proinflammatory
cytokines, such as tumor necrosis factor TNF-alpha, IL-6,
and IL-1beta, on the other hand, pretreatment with TSA
induced an increase in the expression of the immunosuppressive
cytokine IL-10 (Han and Lee, 2009). Dominant negative
survivin protein (SurR9-C84A) on the other hand has shown
promising anti-inflammatory and chondroprotective activity
against cartilage degradation and arthritis (Samarasinghe, 2013).
SurR9-C84A treatments have also shown improved neuronal
health following amyloid-beta (Aβ) peptide fragment and
N-methyl-D-aspartate (NMDA) induced toxicity to brain cells
in addition to inflammatory insults induced in mono and co-
cultures of brain cells in an Alzheimer’s disease (AD) model
(Sriramoju et al., 2015). The BIR motif of mutant survivin
(SurR9-C84A) has been reported to bind with microtubules
and control their stability, instigate cell division, enhance
proliferation and trigger the expression of the cell cycle
to induce proliferation of neurons and to protect them
from apoptosis (Baratchi et al., 2010). Moreover, treatments
of SurR9-C84A have also been reported to protect the
neuronal cells from oxidative damage and peroxide-induced
oxidative stress (Baratchi et al., 2011b). It has also been
reported that SurR9-C84A acts as a neuroprotectant against
the cytotoxic effects of activated T-cell infiltrates, such as
granzyme B (GrB) (Baratchi et al., 2011a). Therefore, there
is enough substantial evidence on the anti-inflammatory,
protective and proliferative nature of both TSA and SurR9-
C84A.
The findings from the present study confirmed that
combined treatment of SurR9-C84A and TSA lead to the
repair of the conjunctival and corneal integrity by reinstating
expression of clathrin and claudin without inducing any
non-specific cytotoxicity. TSA and SurR9-C84A treatment
increased expression of survivin-preventing apoptosis, TGF-
beta-1-initiating wound healing, fibronectin, and alpha
integrin–reinstating the corneal integrity. Key markers of
corneal haze progression (alpha-SMA and collagen type IV) were
effectively downregulated (Figure 7). TSA and SurR9-C84A
treatment further led to the suppression of pro-inflammatory
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markers IL-1beta, IL-6, IL-12, IL-13, IFN-gamma, TNF-alpha,
GMCSF, Rantes, and MMP-2. Thus this combination showed a
promising healing and anti-inflammatory effect in a very short
time post-alkali burn. Hence, this combination can prove to be
a promising ophthalmic formulation for immediate response for
wound healing post-alkali burnt cornea.
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